tiprankstipranks
Trending News
More News >
BioMark Diagnostics (TSE:BUX)
:BUX

BioMark Diagnostics (BUX) Revenue

Compare
3 Followers

BioMark Diagnostics Revenue

BioMark Diagnostics had a revenue of 38.56K in the quarter ending Dec 31, 2024, with 0.56%. This bring the company's revenue in the last twelve months to 155.03K, Increased -1.89%. In the fiscal year ending Mar 31, 2024, BioMark Diagnostics had annual revenue of 163.22K with 6.34% growth.
Revenue (ttm)
155.03K
Revenue Growth
-4.98%
P/S Ratio
194.89
Revenue/Employee
Employees
Market Cap
C$31.81M

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Mar 31, 2024
163.22K9.73K+6.34%
Mar 31, 2023
153.49K109.56K+249.38%
Mar 31, 2022
43.93K+∞%
Mar 31, 2021
0.00-263.28K-100.00%
Mar 31, 2020
263.28K+∞%
Mar 31, 2019
0.00
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis